In REMAP-CAP, ivermectin did not improve organ support-free days in hospitalised COVID-19 patients: median -1 vs -1 in 61 critically ill (OR 0.94) and 22 vs 22 in 89 noncritically ill (OR 1.04). Enrolment stopped for operational futility.
RCTn = 150
Hashmi et al. Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)